Graeme A E Donnelly (Graeme Donnelly)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 11

Top Topics

Attention Deficit Hyperactivity Disorder

Placebo Controlled

Top Venues

Journal of attention disorders

This page only lists publications with an associated author ORCID identifier.

Publications

Vishal Madaan, Sailaja Bhaskar, Graeme A E Donnelly, Daniel J Cox
A Randomized, Phase 3, Double-Blind, Crossover Comparison of Multilayer, Extended-Release Methylphenidate (PRC-063), and Lisdexamfetamine in the Driving Performance of Young Adults With ADHD. Journal of attention disorders (2024)
Vishal Madaan, Sailaja Bhaskar, Graeme A E Donnelly, Daniel J Cox
A Randomized, Phase 3, Double-Blind, Crossover Comparison of Multilayer, Extended-Release Methylphenidate (PRC-063), and Lisdexamfetamine in the Driving Performance of Young Adults With ADHD. Journal of attention disorders 28 (6) (2024)
Vishal Madaan, Sailaja Bhaskar, Graeme A E Donnelly, Daniel J Cox
A Randomized, Phase 3, Double-Blind, Crossover Comparison of Multilayer, Extended-Release Methylphenidate (PRC-063), and Lisdexamfetamine in the Driving Performance of Young Adults With ADHD. Journal of attention disorders 28 (6) (2024)
Vishal Madaan, Sailaja Bhaskar, Graeme A E Donnelly, Daniel J Cox
A Randomized, Phase 3, Double-Blind, Crossover Comparison of Multilayer, Extended-Release Methylphenidate (PRC-063), and Lisdexamfetamine in the Driving Performance of Young Adults With ADHD. Journal of attention disorders 28 (6) (2024)
Vishal Madaan, Sailaja Bhaskar, Graeme A E Donnelly, Daniel J Cox
A Randomized, Phase 3, Double-Blind, Crossover Comparison of Multilayer, Extended-Release Methylphenidate (PRC-063), and Lisdexamfetamine in the Driving Performance of Young Adults With ADHD. Journal of attention disorders 28 (6) (2024)
Vishal Madaan, Sailaja Bhaskar, Graeme A E Donnelly, Daniel J Cox
A Randomized, Phase 3, Double-Blind, Crossover Comparison of Multilayer, Extended-Release Methylphenidate (PRC-063), and Lisdexamfetamine in the Driving Performance of Young Adults With ADHD. Journal of attention disorders (2024)
Judy van Stralen, Gurdeep Parhar, Anita Parhar, Valérie Tourjman, Sohail Khattak, Tahira Ahmed, Graeme A E Donnelly, Jodan Ratz
Real-World Efficacy and Safety of Extended-Release Methylphenidate (PRC-063) in the Treatment of ADHD in Pediatric and Adult Subjects: Results of a Phase IV Multicenter Comparison With Lisdexamfetamine Dimesylate. Journal of attention disorders 27 (7) (2023)
Judy van Stralen, Gurdeep Parhar, Anita Parhar, Valérie Tourjman, Sohail Khattak, Tahira Ahmed, Graeme A E Donnelly, Jodan Ratz
Real-World Efficacy and Safety of Extended-Release Methylphenidate (PRC-063) in the Treatment of ADHD in Pediatric and Adult Subjects: Results of a Phase IV Multicenter Comparison With Lisdexamfetamine Dimesylate. Journal of attention disorders 27 (7) (2023)
Judy van Stralen, Gurdeep Parhar, Anita Parhar, Valérie Tourjman, Sohail Khattak, Tahira Ahmed, Graeme A E Donnelly, Jodan Ratz
Real-World Efficacy and Safety of Extended-Release Methylphenidate (PRC-063) in the Treatment of ADHD in Pediatric and Adult Subjects: Results of a Phase IV Multicenter Comparison With Lisdexamfetamine Dimesylate. Journal of attention disorders (2023)
Marc J Cataldo, Graeme A E Donnelly, Andrew J Cutler, Ann C Childress, Jaromir Mikl, Sailaja Bhaskar, James G Waxmonsky
Analysis of Daily Sleep Diary Measures From Multilayer Extended-Release Methylphenidate (PRC-063) Studies in Children and Adults With ADHD. Journal of attention disorders 26 (14) (2022)
Ann Childress, Andrew J Cutler, Andrea H Marraffino, Sailaja Bhaskar, Graeme A E Donnelly
Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Adult Laboratory Classroom Study of the Efficacy and Safety of PRC-063 (Extended-Release Methylphenidate) for the Treatment of ADHD. Journal of attention disorders (2021)